Publication | Closed Access

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

AnemiaSubcutaneous ErythropoietinHeart FailureCardiovascular DiseaseBlood TransfusionHematologyFunctional Cardiac ClassIron DeficiencyMedicineIntravenous IronCardiologyNephrologyAplastic AnemiaEmergency MedicineAnesthesiology